1Department of Neurology, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea
2Department of Radiology, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea
3Department of Neurology, Seoul Medical Center, Seoul, Korea
Copyright © 2020 Korean Council of Science Editors
This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Rank | Article | No. of citations | No. of annual citations | No. of annual citations, rank |
---|---|---|---|---|
1 | Marler JR, Brott T, Broderick J, et al. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-8. | 5,182 | 259.1 | 3 |
2 | Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial.. Stroke 1993;24:35-41. | 3,673 | 159.7 | 8 |
3 | Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827-38. | 2,914 | 116.6 | 19 |
4 | O'Leary DH, Polak JF, Kronmal RA, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999;340:14-22. | 2,862 | 168.4 | 7 |
5 | MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765-74. | 2,847 | 113.9 | 21 |
6 | Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983-8. | 2,612 | 108.8 | 25 |
7 | Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370-5. | 2,507 | 179.1 | 5 |
8 | Probstfield JL. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-64. | 2,382 | 99.3 | 30 |
9 | Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-29. | 2,221 | 317.3 | 2 |
10 | Sever PS, Dahlöf B, Poulter NR, et al. prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003;361:1149-58. | 2,160 | 180.0 | 4 |
Rank | Journal | No. of articles |
---|---|---|
1 | The Lancet | 25 |
2 | Stroke | 23 |
3 | New England Journal of Medicine | 17 |
4 | JAMA: Journal of the American Medical Association | 12 |
5 | Annals of Neurology | 4 |
6 | Neurology | 4 |
7 | Archives of Internal Medicine | 3 |
8 | Lancet Neurology | 3 |
9 | Annals of Internal Medicine | 2 |
10 | Brain | 1 |
11 | Cerebrovascular Diseases | 1 |
12 | Journal of Cerebral Blood Flow and Metabolism | 1 |
13 | Journal of Neurology Neurosurgery and Psychiatry | 1 |
14 | Journal of the Neurological Sciences | 1 |
15 | Nature Reviews Neuroscience | 1 |
16 | Trends in Neurosciences | 1 |
Rank | Author | No. of top-100 cited articles | Types of author association according to number of top-100 cited articles |
---|---|---|---|
1 | Hacke W | 12 | First (n = 6), corresponding (n = 6) |
2 | Wolf PA | 7 | First (n = 4), corresponding (n = 3) |
3 | Bamford J | 4 | First (n = 2), corresponding (n = 2) |
3 | del Zoppo GJ | 4 | First (n = 2), corresponding (n = 2) |
3 | Feigin VL | 4 | First (n = 2), corresponding (n = 2) |
3 | Smith WS | 4 | First (n = 2), corresponding (n = 2) |
Type of article | No. of articles |
---|---|
Original article | 65 |
Guidelines | 6 |
Stroke classification or stroke related scale | 6 |
Review article or editorial | 7 |
Systematic review or meta-analysis | 13 |
National registry | 3 |
Topic | No. of articles |
---|---|
Stroke risk factor | |
Multiple risk factor | 3 |
Hypertension or blood pressure | 4 |
Diabetes mellitus | 1 |
Dyslipidemia or statin therapy | 4 |
Atrial fibrillation | 5 |
Coagulopathy (fibrinogen, factor V, sickle cell anemia, estrogen) | 4 |
Carotid artery or aortic arch stenosis | 2 |
Homocysteine | 3 |
Diet (vitamin, fruit, alcohol, etc.) | 3 |
Obstructive sleep apnea | 1 |
Patent foramen ovale | 1 |
C-reactive protein | 1 |
Inflammatory mediator | 1 |
Published guidelines | 6 |
Stroke registry | 3 |
Stroke review | 3 |
Stroke diagnosis, pathophysiology | |
Pathophysiology | 6 |
Subtype classification | 3 |
Scale (mRS, NIHSS, etc.) | 3 |
Imaging modalities | 3 |
Stroke management | |
Tissue plasminogen activation (intravenous-tPA) | 9 |
Thrombolysis (intraarterial-urokinase, desmoteplase) | 3 |
Mechanical thrombectomy | 1 |
Decompression surgery | 1 |
Bypass surgery | 1 |
Carotid endarterectomy | 1 |
Antithrombotic therapy (aspirin, clopidogrel, dypiridamole, ticlopidine) | 10 |
Warfarin or anticoagulation | 6 |
Stroke prognosis | |
Dementia | 1 |
Mood | 1 |
Rehabilitation | 1 |
Reorganize or recovery | 5 |
See Suppl. 1 for all 100 articles.
Articles from specific groups whose first or corresponding authors could not be determined (article no.